ScholarIQanswers from OpenAlex

Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma

PaperCitations, authors & open-access status

Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma have?

ScholarIQcitation count

Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma has 66 citations in the OpenAlex counts ScholarIQ stores.

When was Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma published?

ScholarIQyear

Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma has 2016 year in the ScholarIQ index.

What is the open-access status of Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma?

ScholarIQoa status

Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma has diamond oa status in the ScholarIQ index.

What is the DOI of Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma?

ScholarIQdoi

The DOI for Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma is on the source record.

What is the PMID of Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma?

ScholarIQpmid

The PMID for Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma is on the source record.

What is the OpenAlex record for Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma?

ScholarIQopenalex

The OpenAlex for Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial